Stevens Capital Management LP Invests $2.09 Million in HCA Healthcare, Inc. $HCA

Key Points

• Stevens Capital Management opened a new Q4 position in HCA of 4,477 shares valued at about $2.09 million; overall, institutional investors own roughly 62.73% of the stock.
• HCA reported Q1 EPS of $7.15 (missing estimates by $0.04) and revenue of $19.11 billion, and set FY 2026 guidance of 29.10–31.50 EPS versus analysts' consensus near 30.05 EPS.
• HCA declared a quarterly dividend of $0.78 per share (annual $3.12, yield ~0.7%, ex-dividend June 16); insiders sold ~13,714 shares (~$7.05M) in the last 90 days and the stock holds a consensus rating of Moderate Buy with an average target of $517.82.

Stevens Capital Management LP acquired a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 4,477 shares of the company's stock, valued at approximately $2,090,000.

Other hedge funds have also recently made changes to their positions in the company. Palisade Asset Management LLC bought a new position in HCA Healthcare in the third quarter worth about $26,000. Holos Integrated Wealth LLC bought a new position in shares of HCA Healthcare during the 4th quarter worth approximately $29,000. Ares Financial Consulting LLC acquired a new stake in HCA Healthcare in the fourth quarter valued at approximately $31,000. JPL Wealth Management LLC acquired a new position in shares of HCA Healthcare during the third quarter worth $33,000. Finally, Aventura Private Wealth LLC acquired a new stake in shares of HCA Healthcare in the 4th quarter worth $34,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 0.4%

Shares of NYSE HCA opened at $428.94 on Wednesday. The company has a 50 day simple moving average of $495.58 and a two-hundred day simple moving average of $486.47. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The stock has a market cap of $95.16 billion, a price-to-earnings ratio of 14.75, a PEG ratio of 1.36 and a beta of 1.18.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company's revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Analysts forecast that HCA Healthcare, Inc. will post 30.05 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 10.73%.

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 8,020 shares of the firm's stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares of the company's stock, valued at $6,171,357.94. This trade represents a 40.07% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael R. Mcalevey sold 1,694 shares of the business's stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares of the company's stock, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 13,714 shares of company stock worth $7,050,460. Corporate insiders own 1.50% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on HCA. Barclays decreased their price target on HCA Healthcare from $551.00 to $496.00 and set an "overweight" rating for the company in a research note on Monday, April 27th. Oppenheimer decreased their price objective on shares of HCA Healthcare from $540.00 to $520.00 and set an "outperform" rating for the company in a research report on Monday, April 27th. UBS Group upped their price target on shares of HCA Healthcare from $598.00 to $635.00 and gave the company a "buy" rating in a research note on Monday, February 23rd. Stephens lowered their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an "overweight" rating for the company in a research note on Monday, April 27th. Finally, Wells Fargo & Company reduced their target price on HCA Healthcare from $481.00 to $436.00 and set an "equal weight" rating for the company in a research note on Monday, April 27th. Sixteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $517.82.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.